Systemic Lupus Erythematosus in Pregnancy
A 30-year-old primigravida at 20 weeks gestation has systemic lupus erythematosus that has been in remission for 2 years on hydroxychloroquine. Blood pressure is 112/70 mm Hg, urine protein is negative, complement levels are normal, and anti-double-stranded DNA is negative. She asks whether to keep taking her medication. Which of the following is the most appropriate management?
- A.Continue hydroxychloroquine unchangedCorrect
- B.Stop hydroxychloroquine immediately
- C.Replace it with oral prednisolone
- D.Refer to rheumatology for discontinuation
Explanation
Hydroxychloroquine is compatible with pregnancy and lactation and should be continued in every pregnant woman with systemic lupus erythematosus, including those in remission. Continuation halves the risk of flare, and lupus flares in pregnancy are strongly associated with pre-eclampsia, preterm birth, fetal growth restriction, and pregnancy loss. In women with anti-Ro/SSA or anti-La/SSB antibodies, hydroxychloroquine also reduces the risk of congenital heart block and neonatal lupus, an additional reason not to withdraw it. The drug crosses the placenta but has not been associated with an increased rate of congenital malformations in large cohorts, and stopping it removes protection while offering no fetal benefit. Corticosteroids are used to treat flares and are not a maintenance substitute; chronic prednisolone brings gestational diabetes, hypertension, infection, and premature rupture of membranes without hydroxychloroquine's flare-prevention effect. The genuinely contraindicated agents in pregnancy are methotrexate, mycophenolate mofetil, and cyclophosphamide, whereas azathioprine, tacrolimus, and hydroxychloroquine are the mainstays. Ongoing care should include baseline and serial blood pressure, urine protein-to-creatinine ratio, complement and anti-double-stranded DNA monitoring, low-dose aspirin from 12 weeks for pre-eclampsia prophylaxis, and fetal echocardiographic surveillance if anti-Ro or anti-La antibodies are present. Pregnancy is ideally planned after at least 6 months of quiescent disease, as here.
Why each option
- A.
- Correct. Hydroxychloroquine is safe in pregnancy, prevents flares, and reduces congenital heart block in anti-Ro positive women.
- B.
- Withdrawal roughly doubles the flare risk, and flares cause pre-eclampsia, preterm birth, and fetal growth restriction.
- C.
- Steroids treat flares but are not maintenance therapy and add gestational diabetes, hypertension, and infection risk.
- D.
- There is no indication to stop the drug; continuation is the standard of care in lupus pregnancy.
Reference: ACR Reproductive Health in Rheumatic and Musculoskeletal Diseases Guideline, 2020
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank